Prestige Consumer Healthcare Inc. (PBH) — Fair Value Analysis
Base-case fair value (P50): $50.24 · Current price: $51.38 · Verdict: Fairly Valued
The Verdict on PBH
PRESTIGE CONSUMER HEALTHCARE INC (PBH) is currently rated as Fairly Valued based on our proprietary Monte Carlo simulations. The current market price of $51.38 aligns very closely with our median fair value (P50) estimate of $50.24. This indicates a -2.2% against the current price, confirming that the market appears to be pricing PBH appropriately relative to its intrinsic value. Investors should note PBH's operational and financial health is assessed as "average" relative to its sector, a factor integrated into our valuation model.
How PBH stacks up against peers
PBH's "average" quality tier reflects its standing in its sector, influencing the distribution of our Monte Carlo fair value simulations. This "average" rating suggests a balanced risk-reward profile, where its fundamental strengths and weaknesses are largely in line with sector norms. Consequently, our analysis shows the current price of $51.38 reflects this positioning, with the $50.24 fair value indicating little significant divergence. The -2.2% validates this equilibrium, suggesting PBH is neither a glaring bargain nor significantly overstretched when measured against its competitive landscape and underlying fundamentals.
What this means for investors
For investors considering PRESTIGE CONSUMER HEALTHCARE INC, the Fairly Valued verdict means the current price of $51.38 provides minimal immediate discrepancy from our statistically derived fair value of $50.24. While the -2.2% figure does not suggest a strong directional catalyst in either direction, it reinforces the market's current assessment of PBH given its "average" quality tier. Long-term investors may find the current pricing attractive for stability, while short-term traders might seek greater disparity for opportunistic plays. To see the full bear/bull distribution and track PBH's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is PBH overvalued or undervalued right now?
PRESTIGE CONSUMER HEALTHCARE INC (PBH) is currently rated as Fairly Valued. Our median fair value estimate (P50) is $50.24, which is very close to the current price of $51.38.
What is the bear case and bull case for PBH?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. These provide a comprehensive view of potential price scenarios.
How does FairCurve calculate PBH's fair value?
FairCurve calculates PBH's fair value using sophisticated Monte Carlo simulations. This involves running thousands of forward-looking scenarios to determine a statistically robust range for its intrinsic value.
How can I track PBH's fair value as it changes?
You can add PBH to a free FairCurve watchlist to receive daily fair-value updates. FairCurve also automatically re-evaluates PBH's fair value instantly when new earnings or fundamental data are released.